SCHEMBL1305378

SCHEMBL1305378

CCCCCCCCCCCOC(=O)C=CC(=O)OCCCCCCCCCCC

nearest known ligand 0.85

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 4/20 0.85
ATM Q13315 1/20 0.83
MAPT P10636 1/20 0.59
RAB9A P51151 1/20 0.59
NPSR1 Q6W5P4 1/20 0.59
NAAA Q02083 1/20 0.59
TSHR P16473 4/20 0.57
HPGD P15428 1/20 0.57
APP P05067 4/20 0.55
EPHX1 P07099 1/20 0.55
HTT P42858 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
ALDH1A1 P00352 1/20 0.52
CYP3A4 P08684 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11680742 1.00 HCAR2 (0.85) HCAR2ATMMAPTRAB9ANPSR1
SCHEMBL440694 1.00 HCAR2 (0.85) HCAR2ATMMAPTRAB9ANPSR1
SCHEMBL9318682 1.00 HCAR2 (0.85) HCAR2ATMMAPTRAB9ANPSR1
SCHEMBL444960 1.00 HCAR2 (0.85) HCAR2ATMMAPTRAB9ANPSR1
SCHEMBL357423 1.00 HCAR2 (0.85) HCAR2ATMMAPTRAB9ANPSR1
SCHEMBL356935 1.00 HCAR2 (0.85) HCAR2ATMMAPTRAB9ANPSR1
SCHEMBL18209632 1.00 HCAR2 (0.85) HCAR2ATMMAPTRAB9ANPSR1
SCHEMBL7780534 1.00 HCAR2 (0.85) HCAR2ATMMAPTRAB9ANPSR1
SCHEMBL42963 1.00 HCAR2 (0.85) HCAR2ATMMAPTRAB9ANPSR1
SCHEMBL10895119 1.00 HCAR2 (0.85) HCAR2ATMMAPTRAB9ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3176187-B1 FORMALDEHYDE-FREE THERMALLY CURABLE POLYMERS ORGANIK KIMYA SANAYI VE TIC A S (TR) 2019-08-07 EP claimed
EP-3176187-A1 FORMALDEHYDE-FREE THERMALLY CURABLE POLYMERS Organik Kimya Sanayi Ve Tic. A.S. (TR) 2017-06-07 EP claimed
US-20250179243-A1 MAIN CHAIN POLYMER, OPTICAL FILM, METHOD FOR PRODUCING MAIN CHAIN POLYMER, METHOD FOR PRODUCING OPTICAL FILM, AND MULTILAYER FILM TOSOH CORPORATION (JP) 2025-06-05 US disclosed
EP-4455128-A1 MAIN CHAIN POLYMER, OPTICAL FILM, METHOD FOR PRODUCING MAIN CHAIN POLYMER, METHOD FOR PRODUCING OPTICAL FILM, AND MULTILAYER FILM Tosoh Corporation (JP) 2024-10-30 EP disclosed
WO-2023120638-A1 MAIN CHAIN POLYMER, OPTICAL FILM, METHOD FOR PRODUCING MAIN CHAIN POLYMER, METHOD FOR PRODUCING OPTICAL FILM, AND MULTILAYER FILM 東ソー株式会社 2023-06-29 WO disclosed
EP-3388455-B1 VINYL CHLORIDE-BASED COPOLYMER, PROCESS FOR PRODUCING SAME, AND THERMOPLASTIC RESIN COMPOSITION COMPRISING SAME LG CHEMICAL LTD (KR) 2021-04-28 EP disclosed
US-10626208-B2 Vinyl chloride-based copolymer, method for preparing the same, and thermoplastic resin composition containing the same LG CHEM, LTD. (KR) 2020-04-21 US disclosed
EP-3176187-B1 FORMALDEHYDE-FREE THERMALLY CURABLE POLYMERS ORGANIK KIMYA SANAYI VE TIC A S (TR) 2019-08-07 EP disclosed
US-10287377-B2 Method of preparing vinyl chloride-based copolymer and vinyl chloride-based copolymer prepared thereby LG CHEM, LTD. (KR) 2019-05-14 US disclosed
EP-3181601-B1 VINYL-BASED POLYMER AND PREPARATION METHOD THEREFOR LG CHEMICAL LTD (KR) 2019-03-27 EP disclosed
US-10138311-B2 Vinyl-based polymer and method of preparing the same LG CHEM, LTD. (KR) 2018-11-27 US disclosed
US-20100256292-A1 CROSSLINKABLE POLYMER DISPERSIONS, COATING COMPOSITIONS COMPRISING THEM AND USE THEREOF CELANESE EMULSIONS GMBH (DE) 2010-10-07 US disclosed
US-20100179272-A1 Cross-Linkable Polymer Dispersions, Method for the Production Thereof and Use Thereof NUTRINOVA NUTRITION SPECIALTIES & FOOD INGREDIENTS GMBH (DE) 2010-07-15 US disclosed
US-20090312481-A1 POLYVINYL ESTER DISPERSIONS AND THEIR USE CELANESE EMULSIONS GMBH (DE) 2009-12-17 US disclosed
US-20090203832-A1 Process for Preparing Polymer Dispersions, the Resulting Dispersions and Their Use CELANESE EMULSIONS GMBH (DE) 2009-08-13 US disclosed
US-6589917-B2 For drilling subterranean wells such as gas or oil wells M-I LLC 2003-07-08 US disclosed
EP-0790289-B1 Polymeric material for liquid crystal/polymer composite film, record display medium, and use thereof DAINIPPON PRINTING CO LTD (JP) 2001-09-05 EP disclosed
US-5851422-A Polymeric material for liquid crystal/polymer composite film, record display medium, and use thereof DAI NIPPON PRINTING CO., LTD. (JP) 1998-12-22 US disclosed
EP-0790289-A1 Polymeric material for liquid crystal/polymer composite film, liquid crystal/polymer composite film, record display medium, and use thereof DAI NIPPON PRINTING CO., LTD. (JP) 1997-08-20 EP disclosed
US-4210739-A PROVIDES LOW TEMPERATURE FLEXIBILITY AND TENSILE STRENGTH STAUFFER CHEMICAL COMPANY (US) 1980-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250179243-A1 MAIN CHAIN POLYMER, OPTICAL FILM, METHOD FOR PRODUCING MAIN CHAIN POLYMER, METHOD FOR PRODUCING OPTICAL FILM, AND MULTILAYER FILM C9, RNF4, F12 HCAR2 3525/4885ATM 1036/4885MAPT 452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.